| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 370 | $140 | $49.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 260 | $80 | $21.6K |
| J9155 | Injection, degarelix, 1 mg | 7,120 | $1 | $21.4K |
| J3490 | Unclassified drugs | 110 | $170 | $18.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 110 | $60 | $6.2K |
| 55700 | Code deleted December 31, 2025. | 20 | $160 | $3.9K |
| 96402 | In this procedure, the provider administers chemotherapy either subcutaneously, meaning under the skin, or intramuscularly, meaning in muscle. He administers a hormonal anti–neoplastic drug. | 140 | $20 | $3.4K |
| 84403 | The lab analyst performs a test to measure total testosterone, typically in patient serum. | 130 | $30 | $3.3K |
| 84153 | The lab analyst performs testing for total prostate specific antigen, PSA, typically on serum or plasma samples using laboratory analyzers. PSA is a protein the prostate gland produces, and… | 130 | $20 | $2.4K |
| 76872 | The provider inserts an ultrasound probe into the rectum and performs a transrectal ultrasound to assess disorders of the prostate, rectum, and surrounding tissues. | 20 | $90 | $2.1K |